Hypoglycemic Effects of Malonyl-ginsenosides Extracted from Roots of Panax ginseng on Streptozotocin-induced Diabetic Mice

被引:29
作者
Liu, Zhi [1 ,2 ]
Wang, Li-Juan [2 ]
Li, Xiang [3 ]
Hu, Jiang-Ning [4 ]
Chen, Yun [5 ]
Ruan, Chang-Chun [1 ]
Sun, Guang-Zhi [1 ]
机构
[1] Jilin Agr Univ, Inst Agr Modernizat, Changchun 130118, Peoples R China
[2] Jilin Agr Univ, Coll Chinese Med Mat, Changchun 130118, Peoples R China
[3] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK S7N 0X2, Canada
[4] Chungnam Natl Univ, Dept Food Sci & Technol, Taejon 305764, South Korea
[5] Wuhan Univ, Res Ctr Med & Struct Biol, Sch Basic Med Sci, Wuhan 430071, Peoples R China
关键词
antidiabetic; malonyl-ginsenosides; Panax ginseng; plasma glucose; AMERICAN GINSENG; GLYCEMIC CONTROL; PLASMA-GLUCOSE; INSULIN; THERAPY; IDENTIFICATION; COMPLICATIONS; RETINOPATHY; POPULATION; MELLITUS;
D O I
10.1002/ptr.2796
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hypoglycemic effects of malonyl-ginsenosides (MGR), extracted from roots of Panax ginseng, were examined in streptozotocin- (STZ-) induced diabetic mice. Animals received daily intravenous injections of MGR in doses of 30, 60, 120 mg/kg. At a dose of 120 mg/kg, MGR reduced the fasting blood glucose level of diabetic mice by 77.8% (76.7 +/- 8.5 mg/dl versus 345.2 +/- 35.8 mg/dl, P < 0.01). The same dose also showed a marked improvement in glucose tolerance of 80% (75.3 +/- 10.8 mg/dl versus 375.6 +/- 43.3 mg/dl, P < 0.01) in diabetic mice after four days. The alkali hydrolysis productions of MGR, ginseng panaxadiol (PDS), malonic acid and a mixture of malonic acid with PDS, showed no effects on fasting blood glucose levels indicated the hypoglycemic effect of MGR relied on their unique esterified chemical structures. The findings from this study suggest that MGR extracted from Panax ginseng may be prescribed as adjunct to drug treatment for controlling diabetes mellitus. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:1426 / 1430
页数:5
相关论文
共 31 条
[1]   VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL [J].
ABRAIRA, C ;
COLWELL, JA ;
NUTTALL, FQ ;
SAWIN, CT ;
NAGEL, NJ ;
COMSTOCK, JP ;
EMANUELE, NV ;
LEVIN, SR ;
HENDERSON, W ;
LEE, HS .
DIABETES CARE, 1995, 18 (08) :1113-1123
[2]  
[Anonymous], DIAB NAT PLAN ACT
[3]   Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component [J].
Attele, AS ;
Zhou, YP ;
Xie, JT ;
Wu, JA ;
Zhang, L ;
Dey, L ;
Pugh, W ;
Rue, PA ;
Polonsky, KS ;
Yuan, CS .
DIABETES, 2002, 51 (06) :1851-1858
[4]   BELLIDIFOLIN - A POTENT HYPOGLYCEMIC AGENT IN STREPTOZOTOCIN (STZ)-INDUCED DIABETIC RATS FROM SWERTIA-JAPONICA [J].
BASNET, P ;
KADOTA, S ;
SHIMIZU, M ;
NAMBA, T .
PLANTA MEDICA, 1994, 60 (06) :507-511
[5]   Ginsenoside, Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats [J].
Cho, William C. S. ;
Chung, Wai-Shing ;
Lee, Sally K. W. ;
Leung, Albert W. N. ;
Cheng, Christopher H. K. ;
Yue, Kevin K. M. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 550 (1-3) :173-179
[6]   Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice [J].
Chung, SH ;
Choi, CG ;
Park, SH .
ARCHIVES OF PHARMACAL RESEARCH, 2001, 24 (03) :214-218
[7]  
Covington M. B., 2001, Diabetes Spectrum, V14, P154, DOI 10.2337/diaspect.14.3.154
[8]   Anti-hyperglycemic effects of ginseng: Comparison between root and berry [J].
Dey, L ;
Xie, JT ;
Wang, A ;
Wu, J ;
Maleckar, SA ;
Yuan, CS .
PHYTOMEDICINE, 2003, 10 (6-7) :600-605
[9]   RELATIONSHIP OF HYPERGLYCEMIA TO THE LONG-TERM INCIDENCE AND PROGRESSION OF DIABETIC-RETINOPATHY [J].
KLEIN, R ;
KLEIN, BEK ;
MOSS, SE ;
CRUICKSHANKS, KJ .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (19) :2169-2178
[10]   Mediation of β-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats [J].
Lai, DM ;
Tu, YK ;
Liu, IM ;
Chen, PF ;
Cheng, JT .
PLANTA MEDICA, 2006, 72 (01) :9-13